View in EDS HTML Full Text PDF Full Text

Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".

Saved in:
Bibliographic Details
Title: Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".
Authors: Gerischer, Lea1,2 (AUTHOR) lea.gerischer@charite.de, Schroeder‐Braunstein, Jutta3 (AUTHOR), Wabnitz, Guido3 (AUTHOR), Meisel, Andreas1,2,4 (AUTHOR)
Source: Annals of Clinical & Translational Neurology. Jun2026, Vol. 13 Issue 6, p1303-1304. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194450740
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gerischer%2C+Lea%22">Gerischer, Lea</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> lea.gerischer@charite.de</i><br /><searchLink fieldCode="AR" term="%22Schroeder‐Braunstein%2C+Jutta%22">Schroeder‐Braunstein, Jutta</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wabnitz%2C+Guido%22">Wabnitz, Guido</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meisel%2C+Andreas%22">Meisel, Andreas</searchLink><relatesTo>1,2,4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Clinical+%26+Translational+Neurology%22">Annals of Clinical & Translational Neurology</searchLink>. Jun2026, Vol. 13 Issue 6, p1303-1304. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194450740
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/acn3.70403
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: 1303
    Titles:
      – TitleFull: Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gerischer, Lea
      – PersonEntity:
          Name:
            NameFull: Schroeder‐Braunstein, Jutta
      – PersonEntity:
          Name:
            NameFull: Wabnitz, Guido
      – PersonEntity:
          Name:
            NameFull: Meisel, Andreas
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 23289503
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Annals of Clinical & Translational Neurology
              Type: main
ResultId 1